Key findings
- HIV pre-exposure prophylaxis (PrEP) first became available through the Pharmaceutical Benefits Scheme (PBS) on April 1st 2018.
- In the first fifteen months after PBS listing, an estimated 26,520 individuals were dispensed PBS-subsidised PrEP.
- The rate at which people are dispensed PrEP for the first time has declined from approximately 2,000 people per month to 1,000 people per month.
